PT-141 represents a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound acts by enhancing specific receptors within the body, causing to augmented sexual function. Clinical studies have indicated that PT-141 could remarkably address a spectrum of sexual dysfunctions in both